Is tesamorelin meant for weight loss?
The September 2026 US label says tesamorelin (Egrifta SV, Egrifta WR) is not meant for weight-loss care.
Care guide / Take your questions
Keep this list beside you at the visit, or print it. There is room for a pause: an answer that needs explaining is still an unfinished answer.
Read this chapter ↓Keep this question
What is still unanswered?
What health problem are we assessing?
Why is tesamorelin being considered for that problem?
What choices would you discuss if I did not want this medicine?
Tesamorelin increases IGF-1, which is found in blood and helps cells in the body grow.
Beside each answer, note who gave it and what still needs checking. An answer of “not yet known” can be useful if there is a clear way to find out.
The September 2026 US label says tesamorelin (Egrifta SV, Egrifta WR) is not meant for weight-loss care.
No; as of September 2026, tesamorelin is a biologic, a type of medicine whose approval rules bar pharmacies from making their own copies.
No; state medical board guidance calls for sending the patient for an in-person visit when the assessment needs a physical exam.
Ask the person assessing you to explain any term that blocks your understanding. Then say back the plan in your own words. Check whether it matches what they meant.
Before agreeing to ongoing care, bring the product name, the checks and the full bill together. If a key answer is missing, keep it on the list.
For the use, product details and prescriber checks.
For the rule against pharmacies making copies of this type of medicine.
For questions, assessments and arranging needed exams.